Abstract
Given the complexity of the tissue environment after CNS injury, appropriate delivery and deployment of therapeutic agents (e.g. small molecules, nucleic acids, proteins and cells) are as critical as the identification of the therapeutic agents themselves. Biomaterials are non-viable materials devised to interact with biological systems. Taking a plethora of forms ranging from nanoparticles, microspheres, porous scaffolds and hydrogels, biomaterials can be designed to interact with the injured CNS on a molecular, cellular or even tissue level. They have naturally emerged as powerful tools that can navigate therapeutic agents through the spatial and temporal challenges of the ever-evolving milieu in the injured CNS. This chapter highlights the roles that biomaterials play in neuroprotection, repair and regeneration (by protecting molecules and targeting them toward the CNS, sustaining long-term release of drugs and providing structural support for endogenous/transplanted cells) and details the strategies they employ in each of these roles. Overall, the numerous applications of biomaterials in the injured CNS not only illustrate the state of the art but also reflect the trend of biomaterials becoming increasingly engaged in an intimate partnership with therapeutic agents to ultimately materialize effective treatment for CNS injury.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Reddy MK, Labhasetwar V (2009) Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. FASEB J 23(5):1384–1395. doi:10.1096/fj.08-116947
Chen H, Spagnoli F, Burris M, Rolland WB, Fajilan A, Dou HY, Tang JP, Zhang JH (2012) Nanoerythropoietin is 10-times more effective than regular erythropoietin in neuroprotection in a neonatal rat model of hypoxia and ischemia. Stroke 43(3):884–887. doi:10.1161/Strokeaha.111.637090
Kawaguchi AT, Fukumoto D, Haida M, Ogata Y, Yamano M, Tsukada H (2007) Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in the rat: evaluation with photochemically induced thrombosis of the middle cerebral artery. Stroke 38(5):1626–1632. doi:10.1161/STROKEAHA.106.467290
Chen CL, Chang SF, Lee D, Yang LY, Lee YH, Hsu CY, Lin SJ, Liaw J (2008) Bioavailability effect of methylprednisolone by polymeric micelles. Pharm Res 25(1):39–47. doi:10.1007/s11095-007-9484-0
Alconcel SNS, Baas AS, Maynard HD (2011) FDA-approved poly(ethylene glycol)-protein conjugate drugs. Polym Chem 2(7):1442–1448. doi:10.1039/C1py00034a
Owens DE, Peppas NA (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307(1):93–102. doi:10.1016/J.Ijpharm.2005.10.010
Calvo P, Gouritin B, Chacun H, Desmaele D, D’Angelo J, Noel JP, Georgin D, Fattal E, Andreux JP, Couvreur P (2001) Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery. Pharm Res 18(8):1157–1166. doi:10.1023/A:1010931127745
Nance EA, Woodworth GF, Sailor KA, Shih TY, Xu QG, Swaminathan G, Xiang D, Eberhart C, Hanes J (2012) A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Sci Transl Med 4(149):149ra119
Gref R, Luck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk T, Muller RH (2000) ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 18(3–4):301–313
Ishida T, Ichihara M, Wang X, Yamamoto K, Kimura J, Majima E, Kiwada H (2006) Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. J Control Release 112(1):15–25. doi:10.1016/j.jconrel.2006.01.005
Ishihara T, Maeda T, Sakamoto H, Takasaki N, Shigyo M, Ishida T, Kiwada H, Mizushima Y, Mizushima T (2010) Evasion of the accelerated blood clearance phenomenon by coating of nanoparticles with various hydrophilic polymers. Biomacromolecules 11(10):2700–2706. doi:10.1021/Bm100754e
Wang X, Chi N, Tang X (2008) Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur J Pharm Biopharm 70(3):735–740. doi:10.1016/j.ejpb.2008.07.005
Migliore MM, Vyas TK, Campbell RB, Amiji MM, Waszczak BL (2010) Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations. J Pharm Sci 99(4):1745–1761. doi:10.1002/jps.21939
Karatas H, Aktas Y, Gursoy-Ozdemir Y, Bodur E, Yemisci M, Caban S, Vural A, Pinarbasli O, Capan Y, Fernandez-Megia E, Novoa-Carballal R, Riguera R, Andrieux K, Couvreur P, Dalkara T (2009) A nanomedicine transports a peptide caspase-3 inhibitor across the blood–brain barrier and provides neuroprotection. J Neurosci 29(44):13761–13769. doi:10.1523/JNEUROSCI.4246-09.2009
Liu L, Guo K, Lu J, Venkatraman SS, Luo D, Ng KC, Ling EA, Moochhala S, Yang YY (2008) Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood–brain barrier. Biomaterials 29(10):1509–1517. doi:10.1016/j.biomaterials.2007.11.014
Costantino L, Gandolfi F, Tosi G, Rivasi F, Vandelli MA, Forni F (2005) Peptide-derivatized biodegradable nanoparticles able to cross the blood–brain barrier. J Control Release 108(1):84–96. doi:10.1016/j.jconrel.2005.07.013
Ke W, Shao K, Huang R, Han L, Liu Y, Li J, Kuang Y, Ye L, Lou J, Jiang C (2009) Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. Biomaterials 30(36):6976–6985. doi:10.1016/j.biomaterials.2009.08.049
Goppert TM, Muller RH (2005) Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns. J Drug Target 13(3):179–187. doi:10.1080/10611860500071292
Gao X, Tao W, Lu W, Zhang Q, Zhang Y, Jiang X, Fu S (2006) Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration. Biomaterials 27(18):3482–3490. doi:10.1016/j.biomaterials.2006.01.038
Gao X, Chen J, Tao W, Zhu J, Zhang Q, Chen H, Jiang X (2007) UEA I-bearing nanoparticles for brain delivery following intranasal administration. Int J Pharm 340(1–2):207–215. doi:10.1016/j.ijpharm.2007.03.039
Heffernan C, Sumer H, Guillemin GJ, Manuelpillai U, Verma PJ (2012) Design and screening of a glial cell-specific, cell penetrating peptide for therapeutic applications in multiple sclerosis. PLoS One 7(9):e45501. doi:10.1371/journal.pone.0045501
Liu JK, Teng Q, Garrity-Moses M, Federici T, Tanase D, Imperiale MJ, Boulis NM (2005) A novel peptide defined through phage display for therapeutic protein and vector neuronal targeting. Neurobiol Dis 19(3):407–418. doi:10.1016/j.nbd.2005.01.022
Lanza GM, Marsh JN, Hu G, Scott MJ, Schmieder AH, Caruthers SD, Pan D, Wickline SA (2010) Rationale for a nanomedicine approach to thrombolytic therapy. Stroke 41(10 suppl):S42–S44. doi:10.1161/STROKEAHA.110.598656
Takamiya M, Miyamoto Y, Yamashita T, Deguchi K, Ohta Y, Abe K (2012) Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice. Neuroscience 221:47–55. doi:10.1016/j.neuroscience.2012.06.060
Bitner BR, Marcano DC, Berlin JM, Fabian RH, Cherian L, Culver JC, Dickinson ME, Robertson CS, Pautler RG, Kent TA, Tour JM (2012) Antioxidant carbon particles improve cerebrovascular dysfunction following traumatic brain injury. ACS Nano 6(9):8007–8014. doi:10.1021/N0302615f
Pavinatto FJ, Pavinatto A, Caseli L, dos Santos DS, Nobre TM, Zaniquelli MED, Oliveira ON (2007) Interaction of chitosan with cell membrane models at the air-water interface. Biomacromolecules 8(5):1633–1640. doi:10.1021/Bm0701550
Cho Y, Shi R, Ben Borgens R (2010) Chitosan nanoparticle-based neuronal membrane sealing and neuroprotection following acrolein-induced cell injury. J Biol Eng 4(1):2. doi:10.1186/1754-1611-4-2
Gupta D, Tator CH, Shoichet MS (2006) Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials 27(11):2370–2379. doi:10.1016/J.Biomaterials.2005.11.015
Kang CE, Poon PC, Tator CH, Shoichet MS (2009) A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair. Tissue Eng Part A 15(3):595–604. doi:10.1089/Ten.Tea.2007.0349
Cooke MJ, Wang YF, Morshead CM, Shoichet MS (2011) Controlled epi-cortical delivery of epidermal growth factor for the stimulation of endogenous neural stem cell proliferation in stroke-injured brain. Biomaterials 32(24):5688–5697. doi:10.1016/J.Biomaterials.2011.04.032
Wang YF, Cooke MJ, Morshead CM, Shoichet MS (2012) Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury. Biomaterials 33(9):2681–2692. doi:10.1016/J.Biomaterials.2011.12.031
Pean JM, Menei P, Morel O, Montero-Menei CN, Benoit JP (2000) Intraseptal implantation of NGF-releasing microspheres promote the survival of axotomized cholinergic neurons. Biomaterials 21(20):2097–2101. doi:10.1016/S0142-9612(00)00141-1
Lee H, McKeon RJ, Bellamkonda RV (2010) Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury. Proc Natl Acad Sci U S A 107(8):3340–3345. doi:10.1073/Pnas.0905437106
Ikada Y, Tabata Y (1998) Protein release from gelatin matrices. Adv Drug Deliv Rev 31(3):287–301
Nakaguchi K, Jinnou H, Kaneko N, Sawada M, Hikita T, Saitoh S, Tabata Y, Sawamoto K (2012) Growth factors released from gelatin hydrogel microspheres increase new neurons in the adult mouse brain. Stem Cells Int 2012:915160. doi:10.1155/2012/915160
Sakiyama-Elbert SE, Hubbell JA (2000) Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release 65(3):389–402
Taylor SJ, Rosenzweig ES, McDonald JW III, Sakiyama-Elbert SE (2006) Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. J Control Release 113(3):226–235. doi:10.1016/j.jconrel.2006.05.005
Ma J, Tian WM, Hou SP, Xu QY, Spector M, Cui FZ (2007) An experimental test of stroke recovery by implanting a hyaluronic acid hydrogel carrying a Nogo receptor antibody in a rat model. Biomed Mater 2(4):233–240. doi:10.1088/1748-6041/2/4/005
Wei YT, He Y, Xu CL, Wang Y, Liu BF, Wang XM, Sun XD, Cui FZ, Xu QY (2010) Hyaluronic acid hydrogel modified with nogo-66 receptor antibody and poly-L-lysine to promote axon regrowth after spinal cord injury. J Biomed Mater Res B Appl Biomater 95(1):110–117. doi:10.1002/jbm.b.31689
Yano A, Shingo T, Takeuchi A, Yasuhara T, Kobayashi K, Takahashi K, Muraoka K, Matsui T, Miyoshi Y, Hamada H, Date I (2005) Encapsulated vascular endothelial growth factor-secreting cell grafts have neuroprotective and angiogenic effects on focal cerebral ischemia. J Neurosurg 103(1):104–114. doi:10.3171/jns.2005.103.1.0104
Tobias CA, Dhoot NO, Wheatley MA, Tessler A, Murray M, Fischer I (2001) Grafting of encapsulated BDNF-producing fibroblasts into the injured spinal cord without immune suppression in adult rats. J Neurotrauma 18(3):287–301. doi:10.1089/08977150151070937
Winn SR, Lindner MD, Lee A, Haggett G, Francis JM, Emerich DF (1996) Polymer-encapsulated genetically modified cells continue to secrete human nerve growth factor for over one year in rat ventricles: behavioral and anatomical consequences. Exp Neurol 140(2):126–138. doi:10.1006/exnr.1996.0123
Baumann MD, Kang CE, Stanwick JC, Wang Y, Kim H, Lapitsky Y, Shoichet MS (2009) An injectable drug delivery platform for sustained combination therapy. J Control Release 138(3):205–213. doi:10.1016/j.jconrel.2009.05.009
Perale G, Rossi F, Santoro M, Peviani M, Papa S, Llupi D, Torriani P, Micotti E, Previdi S, Cervo L, Sundstrom E, Boccaccini AR, Masi M, Forloni G, Veglianese P (2012) Multiple drug delivery hydrogel system for spinal cord injury repair strategies. J Control Release 159(2):271–280. doi:10.1016/j.jconrel.2011.12.025
Wang Y, Wei YT, Zu ZH, Ju RK, Guo MY, Wang XM, Xu QY, Cui FZ (2011) Combination of hyaluronic acid hydrogel scaffold and PLGA microspheres for supporting survival of neural stem cells. Pharm Res 28(6):1406–1414. doi:10.1007/s11095-011-0452-3
Lin CC, Metters AT (2008) Bifunctional monolithic affinity hydrogels for dual-protein delivery. Biomacromolecules 9(3):789–795. doi:10.1021/bm700940w
Tauro JR, Gemeinhart RA (2005) Matrix metalloprotease triggered delivery of cancer chemotherapeutics from hydrogel matrixes. Bioconjug Chem 16(5):1133–1139. doi:10.1021/bc0501303
Jin K, Mao X, Xie L, Galvan V, Lai B, Wang Y, Gorostiza O, Wang X, Greenberg DA (2010) Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats. J Cereb Blood Flow Metab 30(3):534–544. doi:10.1038/jcbfm.2009.219
Hejcl A, Sedy J, Kapcalova M, Toro DA, Amemori T, Lesny P, Likavcanova-Masinova K, Krumbholcova E, Pradny M, Michalek J, Burian M, Hajek M, Jendelova P, Sykova E (2010) HPMA-RGD hydrogels seeded with mesenchymal stem cells improve functional outcome in chronic spinal cord injury. Stem Cells Dev 19(10):1535–1546. doi:10.1089/scd.2009.0378
Ellis-Behnke RG, Liang YX, You SW, Tay DK, Zhang S, So KF, Schneider GE (2006) Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci U S A 103(13):5054–5059. doi:10.1073/pnas.0600559103
Huang KF, Hsu WC, Chiu WT, Wang JY (2012) Functional improvement and neurogenesis after collagen-GAG matrix implantation into surgical brain trauma. Biomaterials 33(7):2067–2075. doi:10.1016/j.biomaterials.2011.11.040
Park KI, Teng YD, Snyder EY (2002) The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol 20(11):1111–1117. doi:10.1038/nbt751
Elias PZ, Spector M (2012) Implantation of a collagen scaffold seeded with adult rat hippocampal progenitors in a rat model of penetrating brain injury. J Neurosci Methods 209(1):199–211. doi:10.1016/j.jneumeth.2012.06.003
Cholas RH, Hsu HP, Spector M (2012) The reparative response to cross-linked collagen-based scaffolds in a rat spinal cord gap model. Biomaterials 33(7):2050–2059. doi:10.1016/j.biomaterials.2011.11.028
Zeng X, Zeng YS, Ma YH, Lu LY, Du BL, Zhang W, Li Y, Chan WY (2011) Bone marrow mesenchymal stem cells in a three dimensional gelatin sponge scaffold attenuate inflammation. Promote angiogenesis and reduce cavity formation in experimental spinal cord injury. Cell Transplant 20(11–12):1881–1899. doi:10.3727/096368911X566181
Tate CC, Shear DA, Tate MC, Archer DR, Stein DG, LaPlaca MC (2009) Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain. J Tissue Eng Regen Med 3(3):208–217. doi:10.1002/term.154
Hou S, Xu Q, Tian W, Cui F, Cai Q, Ma J, Lee IS (2005) The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin. J Neurosci Methods 148(1):60–70. doi:10.1016/j.jneumeth.2005.04.016
Woerly S, Pinet E, de Robertis L, Van Diep D, Bousmina M (2001) Spinal cord repair with PHPMA hydrogel containing RGD peptides (NeuroGel). Biomaterials 22(10):1095–1111
Wei YT, Tian WM, Yu X, Cui FZ, Hou SP, Xu QY, Lee IS (2007) Hyaluronic acid hydrogels with IKVAV peptides for tissue repair and axonal regeneration in an injured rat brain. Biomed Mater 2(3):S142–S146
Fukushima K, Enomoto M, Tomizawa S, Takahashi M, Wakabayashi Y, Itoh S, Kuboki Y, Shinomiya K (2008) The axonal regeneration across a honeycomb collagen sponge applied to the transected spinal cord. J Med Dent Sci 55(1):71–79
Aota S, Nomizu M, Yamada KM (1994) The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J Biol Chem 269(40):24756–24761
Potter W, Kalil RE, Kao WJ (2008) Biomimetic material systems for neural progenitor cell-based therapy. Front Biosci 13:806–821
Prang P, Muller R, Eljaouhari A, Heckmann K, Kunz W, Weber T, Faber C, Vroemen M, Bogdahn U, Weidner N (2006) The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels. Biomaterials 27(19):3560–3569. doi:10.1016/j.biomaterials.2006.01.053
Stokols S, Sakamoto J, Breckon C, Holt T, Weiss J, Tuszynski MH (2006) Templated agarose scaffolds support linear axonal regeneration. Tissue Eng 12(10):2777–2787. doi:10.1089/ten.2006.12.2777
Chen BK, Knight AM, de Ruiter GCW, Spinner RJ, Yaszemski MJ, Currier BL, Windebank AJ (2009) Axon regeneration through scaffold into distal spinal cord after transection. J Neurotrauma 26(10):1759–1771. doi:10.1089/Neu.2008.0610
Chow WN, Simpson DG, Bigbee JW, Colello RJ (2007) Evaluating neuronal and glial growth on electrospun polarized matrices: bridging the gap in percussive spinal cord injuries. Neuron Glia Biol 3:119–126. doi:10.1017/S1740925x07000580
Hurtado A, Cregg JM, Wang HB, Wendell DF, Oudega M, Gilbert RJ, McDonald JW (2011) Robust CNS regeneration after complete spinal cord transection using aligned poly-L-lactic acid microfibers. Biomaterials 32(26):6068–6079. doi:10.1016/J.Biomaterials.2011.05.006
Stokols S, Tuszynski MH (2004) The fabrication and characterization of linearly oriented nerve guidance scaffolds for spinal cord injury. Biomaterials 25(27):5839–5846. doi:10.1016/j.biomaterials.2004.01.041
Teng YD, Lavik EB, Qu X, Park KI, Ourednik J, Zurakowski D, Langer R, Snyder EY (2002) Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A 99(5):3024–3029. doi:10.1073/pnas.052678899
Wong DY, Krebsbach PH, Hollister SJ (2008) Brain cortex regeneration affected by scaffold architectures. J Neurosurg 109(4):715–722. doi:10.3171/JNS/2008/109/10/0715
Nisbet DR, Rodda AE, Horne MK, Forsythe JS, Finkelstein DI (2009) Neurite infiltration and cellular response to electrospun polycaprolactone scaffolds implanted into the brain. Biomaterials 30(27):4573–4580
Miller C, Jeftinija S, Mallapragada S (2002) Synergistic effects of physical and chemical guidance cues on neurite alignment and outgrowth on biodegradable polymer substrates. Tissue Eng 8(3):367–378. doi:10.1089/107632702760184646
Mahoney MJ, Chen RR, Tan J, Saltzman WM (2005) The influence of microchannels on neurite growth and architecture. Biomaterials 26(7):771–778. doi:10.1016/j.biomaterials.2004.03.015
Dowell-Mesfin NM, Abdul-Karim MA, Turner AM, Schanz S, Craighead HG, Roysam B, Turner JN, Shain W (2004) Topographically modified surfaces affect orientation and growth of hippocampal neurons. J Neural Eng 1(2):78–90. doi:10.1088/1741-2560/1/2/003
Engler AJ, Sen S, Sweeney HL, Discher DE (2006) Matrix elasticity directs stem cell lineage specification. Cell 126(4):677–689. doi:10.1016/j.cell.2006.06.044
Saha K, Keung AJ, Irwin EF, Li Y, Little L, Schaffer DV, Healy KE (2008) Substrate modulus directs neural stem cell behavior. Biophys J 95(9):4426–4438. doi:10.1529/biophysj.108.132217
Leipzig ND, Shoichet MS (2009) The effect of substrate stiffness on adult neural stem cell behavior. Biomaterials 30(36):6867–6878. doi:10.1016/j.biomaterials.2009.09.002
Lee YS, Arinzeh TL (2012) The influence of piezoelectric scaffolds on neural differentiation of human neural stem/progenitor cells. Tissue Eng Part A 18(19–20):2063–2072. doi:10.1089/ten.TEA.2011.0540
Cellot G, Cilia E, Cipollone S, Rancic V, Sucapane A, Giordani S, Gambazzi L, Markram H, Grandolfo M, Scaini D, Gelain F, Casalis L, Prato M, Giugliano M, Ballerini L (2009) Carbon nanotubes might improve neuronal performance by favouring electrical shortcuts. Nat Nanotechnol 4(2):126–133. doi:10.1038/nnano.2008.374
Cellot G, Toma FM, Varley ZK, Laishram J, Villari A, Quintana M, Cipollone S, Prato M, Ballerini L (2011) Carbon nanotube scaffolds tune synaptic strength in cultured neural circuits: novel frontiers in nanomaterial-tissue interactions. J Neurosci 31(36):12945–12953. doi:10.1523/JNEUROSCI.1332-11.2011
Lim TC, Toh WS, Wang LS, Kurisawa M, Spector M (2012) The effect of injectable gelatin-hydroxyphenylpropionic acid hydrogel matrices on the proliferation, migration, differentiation and oxidative stress resistance of adult neural stem cells. Biomaterials 33(12):3446–3455. doi:10.1016/j.biomaterials.2012.01.037
Bencherif SA, Sands RW, Bhatta D, Arany P, Verbeke CS, Edwards DA, Mooney DJ (2012) Injectable preformed scaffolds with shape-memory properties. Proc Natl Acad Sci U S A 109(48):19590–19595. doi:10.1073/pnas.1211516109
Johnson PJ, Tatara A, Shiu A, Sakiyama-Elbert SE (2010) Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant 19(1):89–101. doi:10.3727/096368909X477273
Bible E, Qutachi O, Chau DY, Alexander MR, Shakesheff KM, Modo M (2012) Neo-vascularization of the stroke cavity by implantation of human neural stem cells on VEGF-releasing PLGA microparticles. Biomaterials 33(30):7435–7446. doi:10.1016/j.biomaterials.2012.06.085
Cholas R, Hsu HP, Spector M (2012) Collagen scaffolds incorporating select therapeutic agents to facilitate a reparative response in a standardized hemiresection defect in the rat spinal cord. Tissue Eng Part A 18(19–20):2158–2172. doi:10.1089/ten.TEA.2011.0577
Guo X, Zahir T, Mothe A, Shoichet MS, Morshead CM, Katayama Y, Tator CH (2012) The effect of growth factors and soluble nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord. Cell Transplant 21(6):1177–1197. doi:10.3727/096368911X612503
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lim, T.C., Spector, M. (2014). Biomaterials for CNS Injury. In: Lo, E., Lok, J., Ning, M., Whalen, M. (eds) Vascular Mechanisms in CNS Trauma. Springer Series in Translational Stroke Research, vol 5. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8690-9_18
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8690-9_18
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8689-3
Online ISBN: 978-1-4614-8690-9
eBook Packages: MedicineMedicine (R0)